Skip to content

Author

Kimitoshi Kimura

We have 1 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

[Immune Checkpoint Tim-3 Regulates Microglial Function in Alzheimer's Disease].

It is suggested that Tim-3 acts as a functional checkpoint that limits beneficial microglial responses in AD and that targeting Tim-3 may therefore represent a promising therapeutic strategy for reprogramming microglia and improving disease outcomes.

Kimitoshi Kimura · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.